From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest

EXPLOSIVE EXPOSE: Okyo Pharma – still no real results, the FCA notified and here is what it is hiding!

Published 831 days ago

Okyo Pharma (OKYO) has not updated its website and so has still not filed results which include a P&L, balance sheet or cashflow statement. I have alerted the FCA to this and in a normal world the shares would be suspended. But this is the FCA which will be too busy reading woke porn to actually do anything. So what might Okyo be hiding?

Okyo Pharma finally spills the beans – interim results shocker

Published 831 days ago

As I pinged emails to and fro with the FCA about Okyo’s (OKYO) failure to publish proper results on Friday which should have led to a suspension at 7 AM but did not as the FCA is useless, Okyo has ‘fessed to the bad news.

Okyo Pharma – after the pump and dump now its a share support operation ahead of next bailout fund raise just weeks away

Published 746 days ago

Heaven knows why this US based POS maintains a dual listing on the (sub) Standard List. It really is a cash guzzling crock as we have pointed out on numerous occasions HERE. In the first part of this year Okyo Pharma (OKYO) managed to pump its shares up to 5.5p with a series of spurious and ramptastic RNS’s. Then as the Bulletin Board Morons took they trousers down, whoosh, a $5.5 million funding arranged by the company not its brokers, came in at just 1.85p. Ouch. And double ouch. One hopes that the morons had lubed up.

Okyo Pharma Limited – surely shares should be suspended first thing when the market reopens?

Published 833 days ago

Evil Banksta flags this up on the comments section but this merits a wider audience. This is a disgrace. The great bear, with grammar corrected by myself and a bit of added poison from me, notes:

Notes from Underground – Most read articles for the week ending 8 April

Published 735 days ago

The most-read non-Tom non-Quiz article this week is The View From The Montana Log-Cabin As Gold Puts In A Record Monthly Close….Or Does It? by Nigel Somerville at No 6 or No 12 including Bearcasts.

Tom Winnifrith Bearcast: Driving bad actors out of town this time it is Okyo Pharma

Published 740 days ago

I start with travelling to Greece news. Boy I am tired. Then the latest knob sending me a lawyers letter. Then Okyo Pharma (OKYO) and Argo Blockchain (ARB).

Notes from Underground – Most read articles for the week ending 18 Mar 2023

Published 756 days ago

The most-read non-Tom non-Quiz article this week is Revisiting My Slam-Dunk Sells For 2022 - What A Bunch Of Dogs! by Nigel Somerville at No 2 or No 4 including Bearcasts.

Notes from Underground – Most read articles for the week ending 15 Jan 2023

Published 819 days ago

The most-read non-quiz non-Tom article this week is by Gary Newman with Asiamet Resources has been a terrible investment for me so far, but I'm still hopeful that it could reach production in the end at No 10 or No 17 including Bearcasts.

Tom Winnifrith Bearcast - looking very grim for Kanabo, it is what it does not say today

Published 789 days ago

In today's podcast I remind you to get something in for the special person or people (it is 2023) in your life. I look at Brian Basham's green spoof Net Zero Infrastructure (NZI), BlueJay Mining (JAY), Afentra (AET) and free speech on this site, 8000 for the Footsie and our obsession with round numbers, Okyo Pharma (OKYO) - spoofing on vapours - and Kanabo (KNB)

Tom Winnifrith Bearcast: Virgin Wines will surely wither and die - another IPO disgrace from 2021

Published 761 days ago

In today's podcast I look at Credit Suisse and the banking crisis, bitcoin, gold, Argo Blockchain (ARB), Online Blockchain (OBC), Mode Global (MODE), Okyo Pharma (OKYO), Virgin Wines (WINO) and Versarien (VRS) in light of the bombshell here earlier today.

Notes from Underground – Most read articles for the week ending 25 Feb 2023

Published 777 days ago

I'm thrilled that the most read article last week was the return of the ShareProphets Sunday Pub Quiz, now with the new added feature of working correctly. Otherwise, the most-read non-Tom article this week is  Kurdistan carries a lot of political risk for oil companies, but despite that I view Genel Energy and Gulf Keystone as buys by Gary Newman  at No 3 or No 7 including Bearcasts.


Tom Winnifrith Bearcast - ouzo on my pancakes as its Schadenfreude day at the Welsh Hovel!

Published 782 days ago

The images below should amuse you. Together with the discussions about getting my wife sacked and me killed, Versarien shareholders - egged on by the vile Neill Ricketts - have given it to me in spades over the years. Natch, today is a good day for me. I discuss many lessons learned and where next. 0p. I also look at Okyo Pharma (OKYO) and Kefi Gold & Copper (KEFI).

Notes from Underground – Most read articles for the week ending 18 Feb 2023

Published 784 days ago

The most-read non-Tom article this week is by Chris Bailey, How much do you like being “nudged” by Hargreaves Lansdown?,  at No 2 or No 8 including Bearcasts.

Tom Winnifrith Bearcast- is this ex Jim Mellon stock the biggest joke valuation going?

Published 2457 days ago

Ok, I am back from a 22-24 mile walk which I shall write up tomorrow but if you could smell my feet? I know many of you hav e donated to Woodlarks ahead of next Saturday's 32 mile stroll by myself, Brokerman Dan and Lucian Miers and we have now raised £14,267.88 but to those who have not donated, PLEASE DO SO NOW HERE. In today's podcast I discuss the CBI talking Brexit shite again - it does NOT speak for British industry. I remind you we have no house view, ref Sosandar (SOS). I raise two questions arising out of a Saturday lunch Joshua and I had with Highland Natural Resources (HNR), notably who will back my new goat lending business. And I look at an ex Mellon stock, Okyo Pharma (OKYO), its valuation is a 100% rum and coke and I explain why.

Tom Winnifrith Bearcast - a long term investment I shall never see, its for Joshua and will probably fail

Published 825 days ago

I start with that investment c/o my pal Dave from Chester Zoo, Then I look at Eurasia Mining (EUO), Okyo Pharma (OKYO), Eden Research (EDEN), Nanoco (NAN) - which I may have misnamed in the podcast - Cellular Goods (CBX) and Frontier Developments (FDEV). Tomorrow I have a Julie "Lingerie on Expenses" Meyer treat for you all. It seems she has been a naughty girl (again).

COMPETITION RESULT: The Great ShareProphets New Year Bury Bad News Sweepstakes

Published 834 days ago

On the last trading day before Christmas the Global Shorting Conspiracy counted a total of 31 Red Flag announcements on a day when no-one-is-watching. A record. So was the last trading day before New Year any better? Er….

UK companies with a US Over the Counter Markets listing – what dubious bunch of spoofers

Published 1187 days ago

An issue I have raised frequently concerns poor quality companies listed on London Markets that cite listing on the US Over the Counter Markets as being a key event for their investors.  Some of the Bulletin Board Morons buy into this myth.  For instance if you look at the Tern (TERN) Bulletin Board on London South East website you can see some of the morons complain that the CEO Al Sisto hasn’t manged to list Tern implying that this failure might be depressing the share price as US investors can’t invest into Tern.

Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Time left: 16:11:52